Awakn Life Sciences
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
217 Queen Street West Ste 301, Toronto, ...Website
www.awaknlifesciences.comRevenue
<$5 MillionStock Symbol
AWKN.NEIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Awakn Life Sciences
Awakn Life Sciences is a clinical stage biotechnology company focused on developing therapeutics for substance use and mental health disorders, particularly alcohol use disorder. The company aims to provide breakthrough treatments to addiction sufferers, with a strategy centered on commercializing its research and development pipeline across various channels. With approximately 51 million people affected by alcohol use disorder in the US, UK, and major European markets, Awakn addresses the inadequacies of current treatment options and seeks to enhance patient recovery rates. Awakn collaborates with pharmaceutical companies, state bodies, and research institutes to advance its evidence-based approach to addiction therapy.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Awakn Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Awakn Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Awakn Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Awakn Life Sciences
Earning: See what the market has to say on Awakn Life Sciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Awakn Life Sciences is spiking on competitors!
Click to see if Awakn Life Sciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Awakn Life Sciences launches new products
Funding: Get notified immidiatlly once Awakn Life Sciences has new funding data
Recommended Actions
Find VP level buyers at Awakn Life Sciences
Find more new buyers
Compare Similar Companies to Awakn Life Sciences
Compare insights from companies similar to Awakn Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Awakn Life Sciences
<$5M
1-10
Public
-
2019
N/A
Company Profile Activity
Activity Insights
Awakn Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Awakn Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Awakn Life Sciences.
Awakn Life Sciences Tech Stack
A closer look at the technologies used by Awakn Life Sciences
See more technologies
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move
Left Company
Executive Move
Event
Event
Awakn Life Sciences News & Media
Awakn Life Sciences Announces Receipt of Notice of Non-Compliance with Cboe Exchange Continued Listing Requirements
Toronto, Ontario--(Newsfile Corp. - November 10, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces today that it has received a notice (the "Notice") from Cboe Canada ("Cboe") indicating that Awakn is not in compliance with Section 3.01(3) of Cboe's Listing Manual. Awakn has 90 days to address the non-compliance.The...Awakn Life Sciences Engages Orphan Insight Ltd. to Advance Market Access, Pricing, and Reimbursement Strategies for AWKN-P001 Targeting Severe Alcohol Use Disorder
Toronto, Ontario--(Newsfile Corp. - October 31, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), announces it has engaged Orphan Insight Ltd ("Orphan Insight") to develop and advance market access, pricing, and reimbursement for Awakn's lead program AWKN-P001. AWKN-P001 targets Severe Alcohol Use Disorder (SAUD), the most...Awakn Life Sciences Completes MDMA Zydis(R) ODT Feasibility Study
Toronto, Ontario--(Newsfile Corp. - October 4, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), today announces it has completed a feasibility study for its proprietary formulation of MDMA using Catalent's Zydis® orally disintegrating tablet (ODT) technology. The study, which was initiated in February 2023, evaluated a variety..Awakn Life Sciences Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), shares a corporate update on recent progress. Awakn also announces the closing of the third tranche of its previously announced private placement.Key recent corporate activity: Healthcare services exit completed and burn reduced:..
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Awakn Life Sciences
Sign Up For FreeTo access detailed company insights
Awakn Life Sciences is a clinical stage biotechnology company focused on developing therapeutics for substance use and mental health disorders, particularly alcohol use disorder. The company aims to provide breakthrough treatments to addiction sufferers, with a strategy centered on commercializing its research and development pipeline across variou... Read More
